Scientists have created an injectable drug that generates nanoparticles capable of facilitating the cure of tumor metastasis in the lungs and liver of mice, according to a study published today by the journal Nature. The research, developed by experts at the Houston Methodist Institute (HMRI), could radically transform the treatment of triple negative breast cancer that has spread to the lungs and liver, officials said.

Most cancer deaths, they remember, are caused by the metastasis of a tumor in the lung and liver, for which there is currently no effective treatment. Available drugs offer very limited benefits as they are not able to overcome certain biological barriers that the organism erects and reach the cancer cells at the necessary levels of concentration. More information